135 related articles for article (PubMed ID: 23743279)
1. Synthesis of oligonucleotides with glucosamine at the 3'-position and evaluation of their biological activity.
Luo X; Sugiura T; Nakashima R; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2013 Jul; 23(14):4157-61. PubMed ID: 23743279
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, RNAi activity and nuclease-resistant properties of apolar carbohydrates siRNA conjugates.
Vengut-Climent E; Terrazas M; Lucas R; Arévalo-Ruiz M; Eritja R; Morales JC
Bioorg Med Chem Lett; 2013 Jul; 23(14):4048-51. PubMed ID: 23764303
[TBL] [Abstract][Full Text] [Related]
4. SiRNAs conjugated with aromatic compounds induce RISC-mediated antisense strand selection and strong gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Sato Y; Seyama T
Biochem Biophys Res Commun; 2012 Oct; 426(4):571-7. PubMed ID: 22982308
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of nuclease-resistant siRNAs possessing benzene-phosphate backbones in their 3'-overhang regions.
Ueno Y; Inoue T; Yoshida M; Yoshikawa K; Shibata A; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2008 Oct; 18(19):5194-6. PubMed ID: 18783944
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological properties of chemically modified siRNAs bearing 1-deoxy-D-ribofuranose in their 3'-overhang region.
Taniho K; Nakashima R; Kandeel M; Kitamura Y; Kitade Y
Bioorg Med Chem Lett; 2012 Apr; 22(7):2518-21. PubMed ID: 22377516
[TBL] [Abstract][Full Text] [Related]
7. Palmitic acid-conjugated 21-nucleotide siRNA enhances gene-silencing activity.
Kubo T; Yanagihara K; Takei Y; Mihara K; Morita Y; Seyama T
Mol Pharm; 2011 Dec; 8(6):2193-203. PubMed ID: 21985606
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and properties of novel L-isonucleoside modified oligonucleotides and siRNAs.
Zhang J; Chen Y; Huang Y; Jin HW; Qiao RP; Xing L; Zhang LR; Yang ZJ; Zhang LH
Org Biomol Chem; 2012 Oct; 10(37):7566-77. PubMed ID: 22895883
[TBL] [Abstract][Full Text] [Related]
9. 2'-modified-2-thiothymidine oligonucleotides.
Rajeev KG; Prakash TP; Manoharan M
Org Lett; 2003 Aug; 5(17):3005-8. PubMed ID: 12916967
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of novel siRNAs having thymidine dimers consisting of a carbamate or a urea linkage at their 3' overhang regions and their ability to suppress human RNase L protein expression.
Ueno Y; Naito T; Kawada K; Shibata A; Kim HS; Wataya Y; Kitade Y
Biochem Biophys Res Commun; 2005 May; 330(4):1168-75. PubMed ID: 15823566
[TBL] [Abstract][Full Text] [Related]
11. Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.
Nagahama K; Veedu RN; Wengel J
Bioorg Med Chem Lett; 2009 May; 19(10):2707-9. PubMed ID: 19375912
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of oligonucleotides carrying linker groups at 1'-position of sugar residues.
Ono A; Dan A; Matsuda A
Nucleic Acids Symp Ser; 1993; (29):13-4. PubMed ID: 8247737
[TBL] [Abstract][Full Text] [Related]
13. Functionalization of the 3'-ends of DNA and RNA strands with N-ethyl-N-coupled nucleosides: a promising approach to avoid 3'-exonuclease-catalyzed hydrolysis of therapeutic oligonucleotides.
Terrazas M; Alagia A; Faustino I; Orozco M; Eritja R
Chembiochem; 2013 Mar; 14(4):510-20. PubMed ID: 23362010
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.
Iwase R; Miyao H; Toyama T; Nishimori K
Nucleic Acids Symp Ser (Oxf); 2006; (50):175-6. PubMed ID: 17150874
[TBL] [Abstract][Full Text] [Related]
15. Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.
Iwase R; Toyama T; Nishimori K
Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1451-4. PubMed ID: 18066804
[TBL] [Abstract][Full Text] [Related]
16. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
Bartlett DW; Davis ME
Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of cationic 2'-O-[N-(4-aminobutyl)carbamoyl] modified oligonucleotides.
Seio K; Tokugawa M; Kanamori T; Tsunoda H; Ohkubo A; Sekine M
Bioorg Med Chem Lett; 2012 Apr; 22(7):2470-3. PubMed ID: 22406150
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of different types of end-capping modifications on the stability of oligonucleotides toward 3'- and 5'-exonucleases.
Pandolfi D; Rauzi F; Capobianco ML
Nucleosides Nucleotides; 1999 Sep; 18(9):2051-69. PubMed ID: 10549151
[TBL] [Abstract][Full Text] [Related]
19. Amido-bridged nucleic acids (AmNAs): synthesis, duplex stability, nuclease resistance, and in vitro antisense potency.
Yahara A; Shrestha AR; Yamamoto T; Hari Y; Osawa T; Yamaguchi M; Nishida M; Kodama T; Obika S
Chembiochem; 2012 Nov; 13(17):2513-6. PubMed ID: 23081931
[No Abstract] [Full Text] [Related]
20. Amino-modified and lipid-conjugated dicer-substrate siRNA enhances RNAi efficacy.
Kubo T; Takei Y; Mihara K; Yanagihara K; Seyama T
Bioconjug Chem; 2012 Feb; 23(2):164-73. PubMed ID: 22236254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
